We interrogated a large publicly available data resource derived from thousands of annotated drug response of cancer cell lines to examine co-occurring signatures of drug resistance and found that CTDs mostly appear to have co-occurring resistance with the EGFR-TKI gefitinib. Here, EGFR is linked to cancer.